Effect of bromocriptine on affect and libido in hyperprolactinemia

M. C S Koppelman, B. L. Parry, J. A. Hamilton, S. W. Alagna, Donald (Lynn) Loriaux

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Six women with primary hyperprolactinemia (mean prolactin level, 50 ng/ml) were matched with six normal women on eight factors influencing life style. Observers blind to endocrine status followed the subjects weekly for 10 weeks. Patients took bromocriptine, 2.5 mg twice daily, or placebo in a randomized double-blind sequence with crossover at 5 weeks. The mean Hamilton score for the patients was compatible with mild depression and higher than that for normal subjects during placebo but not during bromocriptine treatment. Libido was similar in both groups during placebo and bromocriptine. The mean number of orgasms reported per day was lower in patients than in normal subjects during both treatment conditions, although one patient reported orgasms during drug treatment only. Hyperprolactinemia in women may be associated with mild depression and a decrease in orgasmic frequency.

Original languageEnglish (US)
Pages (from-to)1037-1041
Number of pages5
JournalAmerican Journal of Psychiatry
Volume144
Issue number8
StatePublished - 1987
Externally publishedYes

Fingerprint

Libido
Hyperprolactinemia
Bromocriptine
Orgasm
Placebos
Depression
Prolactin
Life Style
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Koppelman, M. C. S., Parry, B. L., Hamilton, J. A., Alagna, S. W., & Loriaux, D. L. (1987). Effect of bromocriptine on affect and libido in hyperprolactinemia. American Journal of Psychiatry, 144(8), 1037-1041.

Effect of bromocriptine on affect and libido in hyperprolactinemia. / Koppelman, M. C S; Parry, B. L.; Hamilton, J. A.; Alagna, S. W.; Loriaux, Donald (Lynn).

In: American Journal of Psychiatry, Vol. 144, No. 8, 1987, p. 1037-1041.

Research output: Contribution to journalArticle

Koppelman, MCS, Parry, BL, Hamilton, JA, Alagna, SW & Loriaux, DL 1987, 'Effect of bromocriptine on affect and libido in hyperprolactinemia', American Journal of Psychiatry, vol. 144, no. 8, pp. 1037-1041.
Koppelman MCS, Parry BL, Hamilton JA, Alagna SW, Loriaux DL. Effect of bromocriptine on affect and libido in hyperprolactinemia. American Journal of Psychiatry. 1987;144(8):1037-1041.
Koppelman, M. C S ; Parry, B. L. ; Hamilton, J. A. ; Alagna, S. W. ; Loriaux, Donald (Lynn). / Effect of bromocriptine on affect and libido in hyperprolactinemia. In: American Journal of Psychiatry. 1987 ; Vol. 144, No. 8. pp. 1037-1041.
@article{2858681ce42a4bd786c15a039fc16a5c,
title = "Effect of bromocriptine on affect and libido in hyperprolactinemia",
abstract = "Six women with primary hyperprolactinemia (mean prolactin level, 50 ng/ml) were matched with six normal women on eight factors influencing life style. Observers blind to endocrine status followed the subjects weekly for 10 weeks. Patients took bromocriptine, 2.5 mg twice daily, or placebo in a randomized double-blind sequence with crossover at 5 weeks. The mean Hamilton score for the patients was compatible with mild depression and higher than that for normal subjects during placebo but not during bromocriptine treatment. Libido was similar in both groups during placebo and bromocriptine. The mean number of orgasms reported per day was lower in patients than in normal subjects during both treatment conditions, although one patient reported orgasms during drug treatment only. Hyperprolactinemia in women may be associated with mild depression and a decrease in orgasmic frequency.",
author = "Koppelman, {M. C S} and Parry, {B. L.} and Hamilton, {J. A.} and Alagna, {S. W.} and Loriaux, {Donald (Lynn)}",
year = "1987",
language = "English (US)",
volume = "144",
pages = "1037--1041",
journal = "American Journal of Psychiatry",
issn = "0002-953X",
publisher = "American Psychiatric Association",
number = "8",

}

TY - JOUR

T1 - Effect of bromocriptine on affect and libido in hyperprolactinemia

AU - Koppelman, M. C S

AU - Parry, B. L.

AU - Hamilton, J. A.

AU - Alagna, S. W.

AU - Loriaux, Donald (Lynn)

PY - 1987

Y1 - 1987

N2 - Six women with primary hyperprolactinemia (mean prolactin level, 50 ng/ml) were matched with six normal women on eight factors influencing life style. Observers blind to endocrine status followed the subjects weekly for 10 weeks. Patients took bromocriptine, 2.5 mg twice daily, or placebo in a randomized double-blind sequence with crossover at 5 weeks. The mean Hamilton score for the patients was compatible with mild depression and higher than that for normal subjects during placebo but not during bromocriptine treatment. Libido was similar in both groups during placebo and bromocriptine. The mean number of orgasms reported per day was lower in patients than in normal subjects during both treatment conditions, although one patient reported orgasms during drug treatment only. Hyperprolactinemia in women may be associated with mild depression and a decrease in orgasmic frequency.

AB - Six women with primary hyperprolactinemia (mean prolactin level, 50 ng/ml) were matched with six normal women on eight factors influencing life style. Observers blind to endocrine status followed the subjects weekly for 10 weeks. Patients took bromocriptine, 2.5 mg twice daily, or placebo in a randomized double-blind sequence with crossover at 5 weeks. The mean Hamilton score for the patients was compatible with mild depression and higher than that for normal subjects during placebo but not during bromocriptine treatment. Libido was similar in both groups during placebo and bromocriptine. The mean number of orgasms reported per day was lower in patients than in normal subjects during both treatment conditions, although one patient reported orgasms during drug treatment only. Hyperprolactinemia in women may be associated with mild depression and a decrease in orgasmic frequency.

UR - http://www.scopus.com/inward/record.url?scp=0023230644&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023230644&partnerID=8YFLogxK

M3 - Article

C2 - 3300375

AN - SCOPUS:0023230644

VL - 144

SP - 1037

EP - 1041

JO - American Journal of Psychiatry

JF - American Journal of Psychiatry

SN - 0002-953X

IS - 8

ER -